胸降主动脉夹层行胸主动脉腔内修复术后升主动脉几何形态变化
本研究纳入2009年4月至2021年7月间因急性降主动脉夹层(B型及非A非B型)接受胸主动脉腔内修复术(TEVAR)的102例患者,通过CT血管造影在多平面重建下测量升主动脉长度、直径、面积和体积。中位随访3年显示升主动脉各几何参数无显著变化,体高是升主动脉平均直径及头臂干水平平均主动脉直径的负向预测因子。
要点
- TEVAR术后3年随访期间升主动脉长度、直径、横截面积及体积均无显著变化。
- 体高是升主动脉平均直径(P值=-0.013;B=-8.890)和头臂干水平平均主动脉直径(P值=0.039;B=-14.763)的负向预测因子。
- TEVAR术前79%患者使用平均1.5(±1.2)类降压药,术后升至98%和2.7(±1.0)类。
核心结论
- 本研究数据提示,在严格降压药物治疗下,胸降主动脉TEVAR术后中期随访期间升主动脉未见显著变化。
- 未发现任何可改变的几何参数增加风险因素。
研究设计与样本
- 2009年4月至2021年7月间纳入102例因急性降主动脉夹层(B型及非A非B型)行TEVAR的患者。
- 术后、6个月及此后每年行CT血管造影,在多平面重建下测量主动脉长度、直径和面积。
主要发现
- 65例(58%)为男性,平均年龄66(±11)岁。
- 4例(4%)诊断为结缔组织病。
- TEVAR术前79%患者使用平均1.5(±1.2)类不同降压药,术后升至98%和2.7(±1.0)类。
- TEVAR术后3年随访期间升主动脉长度、直径、横截面积或体积无显著变化。
- 体高是升主动脉平均直径(P值=-0.013;B=-8.890)和头臂干水平平均主动脉直径(P值=0.039;B=-14.763)的负向预测因子。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to assess geometry changes of the ascending aorta after thoracic endovascular aortic repair (TEVAR) for descending aortic dissection and identify potential risk factors for diameter and length change. METHODS: Between April 2009 and July 2021, 102 patients were treated for acute descending aortic dissections (type B and non-A non-B) with TEVAR and were included in this analysis. Computed tomography angiographic scans were transferred to a dedicated imaging software and detailed aortic measurements (including length, diameter and area) were taken in multiplanar reconstruction postoperatively, after 6 months and annually thereafter. RESULTS: Sixty-five (58%) patients were male, with a mean age of 66 (±11). Four (4%) patients were diagnosed with connective tissue disease. Before TEVAR, 79% of our patients were treated with a mean of 1.5 (±1.2) different classes of antihypertensive medications. This number rose to 98% after TEVAR and 2.7 (±1.0) different antihypertensive drugs. There was no significant change in length, diameter, cross-sectional area, or volume of the ascending aorta during the follow-up of 3 years after TEVAR. Body height was a negative predictor for mean ascending aortic diameter (P value = -0.013; B = -8.890) and mean aortic diameter at the level of the brachiocephalic trunk (P value = 0.039; B = -14.763). CONCLUSIONS: Our data suggest no significant changes in the ascending aorta following TEVAR of the descending thoracic aorta during mid-term follow-up when under stringent blood pressure medication. Additionally, we did not find any modifiable risk factors for geometry parameter increase.
引用
- Kletzer J, Berger T, Domin P, et al. Ascending Geometry After Thoracic Endovascular Aortic Repair for Descending Aortic Dissection. Ann Vasc Surg. 2024. PMID: 39098724. doi:10.1016/j.avsg.2024.07.100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。